European Medical Journal Dermatology (Dec 2013)
Skin Reactions Secondary to Anticancer Agents
Abstract
In recent decades, new chemotherapeutic agents have been introduced in cancer therapy. The skin is often the target for the toxicity of these drugs. Skin side-effects may decrease the compliance and the quality of life of these patients. To cure and to prevent these side-effects dermatologists can cooperate with oncologists. In this paper we propose a brief review of the main toxic skin events caused by chemotherapeutic agents, in particular linked to the epidermal growth factor receptor (EGF-R) inhibitor.